Resumen
SARS-CoV-2 virus has been identified as the causative agent of the COVID-19 pandemic. Even when no standard treatment is available, antivirals such as remdesivir and other drugs such as chloroquine and ivermectin, which interfere with viral repli-cation, have been assayed. Some strategies aimed to reduce immune mechanisms, such as the use of tocilizumab and natural antioxidants, have also been tested. The use of drugs related to the renin-angiotensin system has been controversial. Pathogenicity mechanisms, as well as controlled treatments, still have to be studied in detail in order to propose a viable therapeutic option that prevents the entry and replication of the virus or enhances the host immune system.
Título traducido de la contribución | Covid-19: A basic approach to understanding potential treatments |
---|---|
Idioma original | Español |
Páginas (desde-hasta) | 580-585 |
Número de páginas | 6 |
Publicación | Gaceta Medica de Mexico |
Volumen | 156 |
N.º | 6 |
DOI | |
Estado | Publicada - 2020 |
Palabras clave
- Covid-19
- Pharmacological treatments
- Renin-angiotensin system